kidney cancer Archive — Page 2 of 3

Portrait of a smiling woman wearing glasses, a white jacket, and a dark floral blouse.
November 6, 2019

Rathmell receives 2019 Eugene P. Schonfeld Award

The Kidney Cancer Association is recognizing the research accomplishments and leadership achievements of W. Kimryn Rathmell, MD, PhD, with its top honor, the Eugene P. Schonfeld Award.

By Tom Wilemon
February 28, 2019

Achilles’ heel for kidney cancer

The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.

By Vanderbilt Health News
Stylized illustration of a large pink-and-purple rounded mass covered with numerous small red, oval-bodied organisms, with additional organisms scattered across a pink surface and pale background.
January 3, 2019

Therapy Advancement for an Aggressive Lung Cancer

By Tom Wilemon
January 3, 2019

Recent Immunotherapy Approvals from the FDA

By Tom Wilemon
Two older men wearing sunglasses sit aboard a boat on calm water, with a wooded shoreline and a small sailboat in the background.
January 3, 2019

Pay it Forward

By Tom Wilemon
Portrait of W. Kimryn Rathmell wearing glasses, a white blazer, and a navy floral blouse.
May 10, 2018

Grant bolsters kidney cancer immunotherapy research

W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.

By Doug Campbell